We are live on ! Find out more
AL

Aspiriant LLC Portfolio holdings

AUM $4.05B
1-Year Est. Return 19.01%
This Fund
S&P 500
This Quarter Est. Return
+8.73%
1 Year Est. Return
+19.01%
3 Year Est. Return
+47.13%
5 Year Est. Return
+48.95%
10 Year Est. Return
+147.53%
AUM
$2.22B
AUM Growth
+$266M
Cap. Flow
+$98.1M
Cap. Flow %
4.42%
Top 10 Hldgs %
61.54%
Holding
318
New
36
Increased
96
Reduced
118
Closed
10

Sector Composition

Rank Sector Weight
1 Technology 5.68%
2 Financials 2.64%
3 Communication Services 1.25%
4 Healthcare 1.06%
5 Consumer Discretionary 0.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MNA icon
51
IQ ARB Merger Arbitrage ETF
MNA
$252M
$5.12M 0.23%
162,922
-33,285
-17% -$1.04M
IJH icon
52
iShares Core S&P Mid-Cap ETF
IJH
$123B
$5.09M 0.23%
91,865
-4,315
-4% -$219K
JPM icon
53
JPMorgan Chase
JPM
$946B
$5M 0.23%
29,408
+789
+3% +$120K
BRK.A icon
54
Berkshire Hathaway Class A
BRK.A
$1.1T
$4.88M 0.22%
9
SCHX icon
55
Schwab US Large- Cap ETF
SCHX
$71.3B
$4.87M 0.22%
259,224
+1,719
+0.7% +$30.2K
AMZN icon
56
Amazon
AMZN
$2.49T
$4.64M 0.21%
30,543
+764
+3% +$107K
PG icon
57
Procter & Gamble
PG
$352B
$4.49M 0.2%
30,649
+105
+0.3% +$15.6K
VWO icon
58
Vanguard FTSE Emerging Markets ETF
VWO
$119B
$4.3M 0.19%
104,700
-2,912
-3% -$116K
META icon
59
Meta Platforms (Facebook)
META
$1.51T
$4.15M 0.19%
11,722
-396
-3% -$129K
VIOV icon
60
Vanguard S&P Small-Cap 600 Value ETF
VIOV
$1.87B
$3.75M 0.17%
42,407
-22,903
-35% -$1.8M
JNJ icon
61
Johnson & Johnson
JNJ
$644B
$3.6M 0.16%
22,978
+177
+0.8% +$27.1K
VNQ icon
62
Vanguard Real Estate ETF
VNQ
$40.3B
$3.59M 0.16%
40,593
+7,730
+24% +$613K
SCZ icon
63
iShares MSCI EAFE Small-Cap ETF
SCZ
$13.2B
$3.58M 0.16%
57,774
-221
-0.4% -$12.6K
CINF icon
64
Cincinnati Financial
CINF
$28.3B
$3.54M 0.16%
34,261
-52
-0.2% -$5.28K
IYY icon
65
iShares Dow Jones US ETF
IYY
$2.94B
$3.47M 0.16%
29,744
VUG icon
66
Vanguard Growth ETF
VUG
$216B
$3.4M 0.15%
65,688
-270
-0.4% -$13K
PEP icon
67
PepsiCo
PEP
$194B
$3.36M 0.15%
19,793
-11
-0.1% -$1.82K
RY icon
68
Royal Bank of Canada
RY
$294B
$3.27M 0.15%
32,315
UNH icon
69
UnitedHealth
UNH
$390B
$3.05M 0.14%
5,801
+686
+13% +$366K
VONV icon
70
Vanguard Russell 1000 Value ETF
VONV
$20.7B
$3.01M 0.14%
41,540
DLN icon
71
WisdomTree US LargeCap Dividend Fund
DLN
$6.29B
$2.99M 0.13%
45,032
-4,398
-9% -$276K
IWR icon
72
iShares Russell Mid-Cap ETF
IWR
$56.4B
$2.98M 0.13%
38,375
IUSG icon
73
iShares Core S&P US Growth ETF
IUSG
$31.1B
$2.94M 0.13%
28,242
+62
+0.2% +$6.11K
CVX icon
74
Chevron
CVX
$374B
$2.89M 0.13%
19,401
+80
+0.4% +$12.1K
SDG icon
75
iShares MSCI Global Sustainable Development Goals ETF
SDG
$168M
$2.86M 0.13%
+35,305
New +$2.66M

Similar funds

Aspiriant LLC's Q4 2023 Portfolio in Review

As of Q4 2023, Aspiriant LLC held 318 positions worth $2.22B, up 14% from $1.95B the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Aspiriant LLC deployed $98.1M of net new capital in Q4 2023, opening 36 new positions and adding to 96 existing holdings. Its largest new stake was iShares MSCI Global Sustainable Development Goals ETF: 35,305 shares worth $2.86M.

By sector, the portfolio is most concentrated in Technology at 5.7% of assets, down from 6.1% a quarter earlier, followed by Financials and Communication Services.

On the sell side, the largest reduction was iShares MSCI Global Min Vol Factor ETF, an estimated $14.2M trimmed.

  • Aspiriant LLC's largest Q4 2023 buy was iShares MSCI Global Sustainable Development Goals ETF: 35,305 shares worth $2.86M.
  • Aspiriant LLC added most to Vanguard Tax-Exempt Bond Index Fund in Q4 2023, an estimated $60.8M increase.
  • Aspiriant LLC's biggest Q4 2023 reduction was iShares MSCI Global Min Vol Factor ETF, cutting an estimated $14.2M.
  • Aspiriant LLC fully exited Lam Research in Q4 2023, selling an estimated $239K.
  • Aspiriant LLC's ten largest holdings make up 62% of its $2.22B portfolio in Q4 2023.
  • Aspiriant LLC opened 36 new positions and closed 10 in Q4 2023.
  • Aspiriant LLC's portfolio value rose 14% quarter-over-quarter to $2.22B.

Based on Aspiriant LLC's 13F filing for Q4 2023, filed 26 Jan 2024.